Comparing Anteris Technologies Global (NASDAQ:AVR) & Sonova (OTCMKTS:SONVY)

Anteris Technologies Global (NASDAQ:AVR) and Sonova (OTCMKTS:SONVY) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Anteris Technologies Global and Sonova, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1	0	1	0	2.00
Sonova	2	4	1	1	2.13

Anteris Technologies Global currently has a consensus target price of $15.00, indicating a potential upside of 143.51%. Given Anteris Technologies Global’s higher probable upside, equities analysts clearly believe Anteris Technologies Global is more favorable than Sonova.

Valuation & Earnings

This table compares Anteris Technologies Global and Sonova”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$2.70 million	94.00	-$76.29 million	($1.81)	-3.40
Sonova	$4.36 billion	3.42	$610.01 million	N/A	N/A

Sonova has higher revenue and earnings than Anteris Technologies Global.

Volatility and Risk

Anteris Technologies Global has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Sonova has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Profitability

This table compares Anteris Technologies Global and Sonova’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-3,944.93%	-252.71%	-169.61%
Sonova	N/A	N/A	N/A

Institutional and Insider Ownership

0.0% of Sonova shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by company insiders. Comparatively, 0.0% of Sonova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Sonova beats Anteris Technologies Global on 9 of the 12 factors compared between the two stocks.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.